Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

227 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Lung cancer in never smokers--a review.
Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ. Couraud S, et al. Among authors: zalcman g. Eur J Cancer. 2012 Jun;48(9):1299-311. doi: 10.1016/j.ejca.2012.03.007. Epub 2012 Mar 28. Eur J Cancer. 2012. PMID: 22464348 Review.
Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer.
Zalcman G, Trédaniel J, Schlichtholz B, Urban T, Milleron B, Lubin R, Meignin V, Couderc LJ, Hirsch A, Soussi T. Zalcman G, et al. Int J Cancer. 2000 Jan 20;89(1):81-6. doi: 10.1002/(sici)1097-0215(20000120)89:1<81::aid-ijc13>3.0.co;2-i. Int J Cancer. 2000. PMID: 10719735
Splice mutations in the p53 gene: case report and review of the literature.
Holmila R, Fouquet C, Cadranel J, Zalcman G, Soussi T. Holmila R, et al. Among authors: zalcman g. Hum Mutat. 2003 Jan;21(1):101-2. doi: 10.1002/humu.9104. Hum Mutat. 2003. PMID: 12497643 Review.
Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study).
Morère JF, Bréchot JM, Westeel V, Gounant V, Lebeau B, Vaylet F, Barlési F, Urban T, Souquet PJ, Debieuvre D, Baudrin L, Zalcman G, Morin F, Milleron B, Moro-Sibilot D. Morère JF, et al. Among authors: zalcman g. Lung Cancer. 2010 Dec;70(3):301-7. doi: 10.1016/j.lungcan.2010.03.003. Epub 2010 Apr 18. Lung Cancer. 2010. PMID: 20400201 Clinical Trial.
Integrating biomarkers into clinical trials: methodological issues for a new paradigm in nonsmall cell lung cancer.
Zalcman G, Bergot E, Creveuil C, Levallet G, Lechapt E. Zalcman G, et al. Curr Opin Oncol. 2011 Jan;23(1):106-11. doi: 10.1097/CCO.0b013e3283412eca. Curr Opin Oncol. 2011. PMID: 21076302 Review.
[Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues].
Bergot E, Levallet G, Creveuil C, Lechapt E, Zalcman G. Bergot E, et al. Among authors: zalcman g. Presse Med. 2011 Apr;40(4 Pt 1):379-88. doi: 10.1016/j.lpm.2011.01.016. Epub 2011 Mar 3. Presse Med. 2011. PMID: 21376511 Review. French.
Admission of advanced lung cancer patients to intensive care unit: a retrospective study of 76 patients.
Andréjak C, Terzi N, Thielen S, Bergot E, Zalcman G, Charbonneau P, Jounieaux V. Andréjak C, et al. Among authors: zalcman g. BMC Cancer. 2011 May 2;11:159. doi: 10.1186/1471-2407-11-159. BMC Cancer. 2011. PMID: 21535895 Free PMC article.
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.
Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Bennouna J, Tredaniel J, Ducoloné A, Lebitasy MP, Baudrin L, Laporte S, Milleron B; Intergroupe Francophone de Cancérologie Thoracique. Quoix E, et al. Among authors: zalcman g. Lancet. 2011 Sep 17;378(9796):1079-88. doi: 10.1016/S0140-6736(11)60780-0. Epub 2011 Aug 8. Lancet. 2011. PMID: 21831418 Clinical Trial.
Chemotherapy in elderly patients with advanced non-small cell lung cancer.
Quoix E, Westeel V, Zalcman G, Milleron B. Quoix E, et al. Among authors: zalcman g. Lung Cancer. 2011 Dec;74(3):364-8. doi: 10.1016/j.lungcan.2011.06.006. Epub 2011 Sep 3. Lung Cancer. 2011. PMID: 21893363 Review.
High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway.
Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, de Fraipont F, Brambilla E, Levallet J, Morin F, Westeel V, Wislez M, Quoix E, Debieuvre D, Dubois F, Rouquette I, Pujol JL, Moro-Sibilot D, Camonis J, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique (IFCT). Levallet G, et al. Among authors: zalcman g. Mol Cancer Ther. 2012 May;11(5):1203-13. doi: 10.1158/1535-7163.MCT-11-0899. Epub 2012 Mar 12. Mol Cancer Ther. 2012. PMID: 22411898 Clinical Trial.
227 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback